Background: Infantile hemangiomas are the most common
tumor of infancy. Propranolol hydrochloride has been
prescribed for decades in the pediatric population for a
variety of disorders. Since 2008 propranolol has replaced
corticosteroids to become the first line of treatment for
infantile hemangioma due to its high effectiveness and low
rate of side effects. Of the side effects reported, the most
serious yet rare side effects include: hypoglycemia,
bronchial hyper-responsiveness, hypotension and
Objective: To describe the effects and side effects of propranolol treatment among 100 pediatric patients.
Conclusion: Propranolol has a long history of safe and effective use in infants and children, and was well tolerated in our study. Understanding and recognition of deleterious adverse effects is critical for physicians and caregivers. Outpatient treatment is possible if parents follow strict guidelines. Educating parents about mild and transient symptoms could prevent unnecessary concern.
Danielle H, Dor L, Avraham L
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2018 All rights reserved. iMedPub LTD Last revised : June 17, 2018